We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Microarray Licence to the Norwegian Microarray Consortium

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

Oxford Gene Technology (OGT) has announced that it has granted a microarray licence to the Norwegian Microarray Consortium (NMC).

This licence allows the NMC to extend its microarray sales into European territories covered by the OGT Southern array patents. 

Dr Mike Evans, Chief Executive of OGT, said, “We are happy to support the NMC by granting this licence and thus further the use of microarray technology”.

Professor Ola Myklebost, Head of the NMC and the FUGE National Microarray Platform, said, “The agreement with OGT means that the National Microarray Platform can now offer all of its array products, including those for academic use, to customers in the UK, France, Germany, Italy, Austria, Belgium, Sweden, Switzerland, Luxembourg and The Netherlands”.